Skip to main content
SpringerLink
Log in

Principles and Biophysics of Dialysis

  • Chapter
Replacement of Renal Function by Dialysis

Abstract

Intermittent dialysis therapy is used in chronic uremia to re-establish body water solute concentrations that cannot be achieved by the natural organ. In this sense, the dialyzer becomes an artificial kidney and it is through the transport of substances by this device that chemical and biophysical control consistent with continued survival is achieved. The chapter is organized as shown in Figure 1 and will consist of two basic lines of development:

  1. 1.

    Consideration of the dialyzer and its operating principles,

  2. 2.

    Consideration of the patient-dialyzer system with regard to solute control in intermittent dialysis therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Michaels AS: Operating parameters and performance criteria for hemodialyzers and other membrane- separation devices. Trans Am Soc Artif Intern Organs 12: 387, 1966

    PubMed  CAS  Google Scholar 

  2. Gotch FA, Autian J, Colton CK, Ginn HE, Lipps BJ, Lowrie EG: The Evaluation of Hemodialyzers. DHEW Publ no (NIH) 72–103: 7, 1971

    Google Scholar 

  3. Babb AL, Popovich RP, Christopher TG, Scribner BH: The genesis of the square meter-hour hypothesis. Trans Am Soc Artif Intern Organs 17: 81, 1971

    PubMed  CAS  Google Scholar 

  4. Klein E: Membranes and materials evaluation. Proc 7th Annual Contractors’ Conf. Artif Kidney- Chronic Uremia Program NIAMDD edited by Krueger KK, DHEW publ no (NIH) 75–248:85, 1974

    Google Scholar 

  5. Gotch FA, Sargent JA, Keen ML, Seid MA, Foster R: Comparative treatment time with Kiil, Gambro and Cordis-Dow Kidneys. Proc Clin Dial Transpl Forum 3: 217, 1973

    CAS  Google Scholar 

  6. Model FS, Davis HJ, Gordon MG: Prepare and evaluate optimized hemodialysis membranes. Proc 8th Annual Contractors Conf Artif Kidney — Chronic Uremia Program NIAMDD edited by Mackey BB, DHEW publ no (NIH) 76–248:71, 1975

    Google Scholar 

  7. Klein E, Lindholm DD, Smith JK, Holland FF: Study of synthetic polypeptides for hemodialysis membranes. Proc 7th Annual Contractors’ Conf Artif Kidney — Chronic Uremia Program NIAMDD edited by Krueger KK, DHEW publ no (NIH) 75–248:75, 1974

    Google Scholar 

  8. Barbour BH, Bernstein M, Cantor PA, Fisher BS, Stone W Jr: Clinical use of NISR 440 polycarbonate membrane for hemodialysis. Trans Am Soc Artif Intern Organs 21: 144, 1975

    PubMed  CAS  Google Scholar 

  9. Wolf AV, Remp DG, Kiley JE, Currie GD: Artificial kidney function: Kinetics of Hemodialysis. J Clin Invest 30: 1062, 1951

    Article  PubMed  CAS  Google Scholar 

  10. Smith HW: The Kidney: Structure and Function in Health and Disease. New York, Oxford University Press, 1951, p 39

    Google Scholar 

  11. Gotch FA: Hemodialysis: Technique and kinetic considerations. Chapter 41 in The Kidney, edited by Brenner BM, Rector FC Jr, Philadelphia, WB Saunders Company, 1976, p 1673

    Google Scholar 

  12. Nolph KD, Nothum RJ, Mäher, JF: Effects of ultrafiltration on dialysance in commercially available coils. Kidney Int 2: 293, 1972

    Article  PubMed  CAS  Google Scholar 

  13. Nolph KD, Nothum RJ, Maher JF: Ultrafiltration: A mechanism for removal of intermediate molecular weight substances in coil dialyzers. Kidney Int 6: 55, 1974

    Article  PubMed  CAS  Google Scholar 

  14. Farrell PC, Babb AL: Estimation of the permeability of cellulosic membranes from solute dimensions and diffusivities.J Biomed Mater Res 7: 25, 1973

    Google Scholar 

  15. Bottomley S, Parsons FM, Broughton PMG: The dialysis of non-electrolytes through regenerated cellulose (Cuprophane). I. The effect of molecular size: J Appl Polym Sci 16: 2115, 1972

    Article  CAS  Google Scholar 

  16. Babb AL, Farrell PC, Uvelli DA, Scribner BH: Hemodialyzer evaluation by examination of solute molecular spectra. Trans Am Soc Artif Intern Organs 18: 98, 1972

    Article  PubMed  CAS  Google Scholar 

  17. Popovich RP, Hlavinka DJ, Bomar JB, Moncrief JW, Decherd JF: The consequences of physiological resistances on metabolite removal from the patient — artificial kidney system. Trans Am Soc Artif Intern Organs 21: 108, 1975

    PubMed  CAS  Google Scholar 

  18. French D: The Schardinger dextrins. Adv Carbohydrate Chem 12: 189, 1957

    CAS  Google Scholar 

  19. Horowitz HI: Uremic toxins and platelet function. Arch Intern Med 127–823, 1970

    Google Scholar 

  20. Cohen BD: Guanidinosuccinic acid in uremia. Arch Intern Med 126: 846, 1970

    Article  CAS  Google Scholar 

  21. Giovannetti S, Biagini M, Cioni L: Evidence that methyl guanidine is retained in chronic renal failure. Experientia 24: 341, 1968

    Article  PubMed  CAS  Google Scholar 

  22. Schmidt EG, McElvain NS, Bowen JJ: Plasma amino acids and the ether soluble phenols in uremia. Am J Clin Path 20: 253, 1950

    PubMed  CAS  Google Scholar 

  23. Gordon A, Bergström J, Fürst P, Zimmerman L: Separation and characterization of uremic metabolites in biologic fluids: A screening approach to the definition of uremic toxins. Kidney Int 7 (suppl): S45, 1975

    Article  Google Scholar 

  24. Giovannetti S, Barsotti G: Dialysis of methylguanidine. Kidney Int 6: 177, 1974

    Article  PubMed  CAS  Google Scholar 

  25. Fürst P, Bergström J, Gordon A, Johnsson E, Zimmerman L: Separation of peptides of “middle” molecular weight from biological fluids of patients with uremia. Kidney Int 7 (suppl): S272, 1975

    Google Scholar 

  26. Funck-Brentano JL, Man NK, Sausse A, Zingraff J, Boudet J, Becker A, Cueille GF: Characterization of a 1100–1300 MW uremic neurotoxin. Trans Am Soc Artif Intern Organs 22: 163, 1976

    PubMed  CAS  Google Scholar 

  27. Pitts RF: Physiology of the Kidney and Body Fluids. Chicago, Year Book Medical Publishers, Inc, 1968, p 181

    Google Scholar 

  28. Bartsch HJ: Handbook of Mathematical Formulas. Translated by Liebscher H, New York, Academic Press, 1974, p 139

    Google Scholar 

  29. Walser M, Bodenlos LJ: Urea metabolism in man. J Clin Invest 38: 1617, 1959

    Article  PubMed  CAS  Google Scholar 

  30. Lowrie EG, Steinberg SM, Galen MA, Gagneux SA, Lazarus JM, Gottlieb MN, Merrill JP: Factors in the dialysis regimen which contribute to alterations in the abnormalities of uremia. Kidney Int 10: 409, 1976

    Article  PubMed  CAS  Google Scholar 

  31. Kreyszig E: Advanced Engineering Mathematics New York, John Wiley and Sons, 1972, p 24, 147

    Google Scholar 

  32. Sokolnikoff IS, Redheffer RM: Mathematics of Physics and Modern Engineering. New York, McGraw Hill, 1958,p 23, 756

    Google Scholar 

  33. Giovannetti S, Maggiore Q: A low nitrogen diet with proteins of high biological value for severe chronic uremia. Lancet 1: 1000, 1964

    Article  PubMed  CAS  Google Scholar 

  34. Shaw AB, Bazzard FJ, Booth EM, Nilwarangkur S, Berlyne GM: The treatment of chronic renal failure by modified Giovannetti diet. QJ Med 34: 237, 1965

    CAS  Google Scholar 

  35. Kerr DNR, Robson A, Elliott RW, Ashcroft R: Diet in chronic renal failure. Proc Roy Soc Med 60: 115, 1967

    PubMed  CAS  Google Scholar 

  36. Franklin SS, Gordon A, Kleeman CR, Maxwell MH: Use of a balanced low-protein diet in chronic renal failure. JAMA 202: 477, 1967

    Article  PubMed  CAS  Google Scholar 

  37. Kopple JD, Sorensen MK, Coburn JW, Gordon A, Rubini ME: Controlled comparison of 20 g and 40 g protein diets in the treatment of chronic uremia. Am J Clin Nutr 21: 553, 1968

    PubMed  CAS  Google Scholar 

  38. Hewlett AW, Gilbert QO, Wickett AD: The toxic effects of urea on normal individuals. Arch Int Med 18: 636, 1916

    Article  CAS  Google Scholar 

  39. Grollman EF, Grollman A: Toxicity of urea and its role in the pathogenesis of uremia. J. Clin Invest 38: 749, 1959

    Article  PubMed  CAS  Google Scholar 

  40. Wineman RJ, Sargent JA, Piercy L: The dietitian’s role in quantitative studies of dialysis therapy. J Am Diet Assoc 1978

    Google Scholar 

  41. Sargent JA, Gotch FA: The analysis of concentration dependence of uremic lesions in clinical studies. Kidney Int 1 (suppl): S35, 1975

    Google Scholar 

  42. Gotch FA, Sargent JA, Keen ML, Lee M: Individualized, quantified dialysis therapy of uremia. Proc Clin Dial Transpl Forum 4: 27, 1974

    Google Scholar 

  43. Gotch FA, Farrell PC, Sargent JA: Theoretical considerations on molecular transport in dialysis and sorbent therapy for uremia. J Dialysis 1: 105, 1976

    Google Scholar 

  44. Dombeck DH, Klein E, Wendt RP: Evaluation of two pool model for predicting serum creatinine levels during intra and interdialytic periods. Trans Am Soc Artif Intern Organs 21: 117, 1975

    PubMed  CAS  Google Scholar 

  45. Sanfelippo ML, Hall DA, Walker WE, Swenson RS: Quantitative evaluation of hemodialysis therapy using a simple mathematical model and a programmable pocket calculator. Trans Am Soc Artif Intern Organs 21: 125, 1975

    PubMed  CAS  Google Scholar 

  46. Katz MA, Hull AR: Transcellular creatinine disequilibrium and its significance in hemodialysis. Nephron 12: 171, 1974

    Article  PubMed  CAS  Google Scholar 

  47. Bleiler RE, Schedl HP: Creatinine excretion: variability and relationships to diet and body size. J Lab Clin Med 59: 945, 1962

    PubMed  CAS  Google Scholar 

  48. Walser M: The conservative management of the uremic patient. In The Kidney, edited by Brenner BM, Rector FC Jr, Philadelphia, WB Saunders Company, 1976, p 1618

    Google Scholar 

  49. Gotch FA, Sargent JA, Keen ML, Lam M, Prowitt M, Grady M, Schoenfeld P, Borah M, Wolfson M, Piercy L, Leddy E, Humphreys M: The solute kinetics of intermittent dialysis therapy. Second Annual Report to Artificial Kidney — Chronic Uremia Program NIAMDD 1976, p 40 (unpublished)

    Google Scholar 

  50. Swan RC, Pitts RF: Neutralization of infused acid by nephrectomized dogs. J Clin Invest 34: 205, 1955

    Article  PubMed  CAS  Google Scholar 

  51. Gotch FA, Borah M, Keen M, Sargent J, Schoenfeld P, Ayus C, Humphreys M: The solute kinetics of intermittent dialysis therapy (IDT). Proc 10th Annual Contractors Conf Artif Kidney - Chronic Uremia Program NIAMDD 1977, p 104

    Google Scholar 

  52. Graefe U, Milutinovich J, Follette W, Vizzo J, Scribner BH: Effect of high efficiency dialysis on acid-base balance and patient “well being”. Am Soc Nephrol (Abstracts) 9: 31, 1976

    Google Scholar 

  53. Mion CM, Hegstrom RM, Boen ST, Scribner BH: Substitution of sodium acetate for sodium bicarbonate in the bath fluid for hemodialysis. Trans Am Soc Artif Intern Organs 10: 110, 1964

    PubMed  CAS  Google Scholar 

  54. Mahler HR, Cordes EH: Biological Chemistry, New York, Harper and Row, 1971, p 595

    Google Scholar 

  55. Schwartz WB, Jenson RL, Relman SA: The disposition of acid administered to sodium-depleted subjects: the renal response and the role of the whole body buffers. J Clin Invest 33: 587, 1954

    Article  PubMed  CAS  Google Scholar 

  56. Schwartz WB, Orning KJ, Porter R: The internal distribution of hydrogen ions with varying degrees of metabolic acidosis. J Clin Invest 36: 373, 1957

    Article  PubMed  CAS  Google Scholar 

  57. Gotch FA, Borah MF, Keen ML, Lam MA, Prowitt MH, Sargent JA: The solute kinetics of intermittent dialysis therapy. Third Annual Report to Artificial Kidney — Chronic Uremia Program NIAMDD 1977, p 48 (unpublished)

    Google Scholar 

  58. Garella S, Dana CL, Chazan JA: Severity of metabolic acidosis as a determinant of bicarbonate requirements. N Engl J Med 289: 121, 1973

    Article  PubMed  CAS  Google Scholar 

  59. Weiner MW: The role of acetate in dialysate for hemodialysis. An investigation using biochemical and radio-spirometric techniques. First Annual Report to Artificial Kidney — Chronic Uremia Program NIAMDD 1976, p 108 (unpublished)

    Google Scholar 

  60. Krebs HA: The biochemical lesion in ketosis. Arch Intern Med 107: 119, 1961

    Article  Google Scholar 

  61. Lundquist F: Production and utilization of free acetate in man. Nature 193: 579, 1962

    Article  PubMed  CAS  Google Scholar 

  62. Sargent JA: The role of acetate in acid-base correction during hemodialysis treatment. Doctoral Dissertation University of California, Berkeley, 1976

    Google Scholar 

  63. Burzynski SR: Biologically active peptides in human urine: I. Isolation of a group of medium size peptides. Physiol Chem Physics 5: 437, 1973

    CAS  Google Scholar 

  64. Shinaberger JH, Miller JH, Rosenblatt MG, Gardner PW, Carpenter GW, Martin FE: Clinical studies of “low flow” dialysis with membranes highly permeable to middle weight molecules. Trans Am Soc Artif Intern Organs 18: 82, 1972

    Article  PubMed  CAS  Google Scholar 

  65. Rattazzi T, Wathen R, Comty C, Raij L, Leonard A, Shapiro F: The comparison of low flow (QD 200) to regular flow (QD 500) dialysis. Trans Am Soc Artif Intern Organs 20: 402, 1974

    Google Scholar 

  66. Scribner BH, Babb AL: Evidence for toxins of middle molecular weight. Kidney Int 7 (suppl): S349, 1975

    Google Scholar 

  67. Ginn HE, Teschan PE, Walker PJ, Bourne JR, Macalyne F, Ward JW, McLain LW, Johnson HB, Hamel B; Neurotoxicity in uremia. Kidney Int 1 (suppl): S357, 1975

    Google Scholar 

  68. Tenckhoff H, Curtis FK: Experience with maintenance peritoneal dialysis in the home. Trans Am Soc Artif Intern Organs 16: 90, 1970

    PubMed  CAS  Google Scholar 

  69. Bell RL, Curtis FK, Babb AL: Analog simulation of the patient — artificial kidney system. Trans Am Soc Artif Intern Organs 11: 183, 1965

    Article  PubMed  CAS  Google Scholar 

  70. Popovich RP: Physiological transport parameters in patients in peritoneal and hemodialysis. First Annual Report to Artificial Kidney — Chronic Uremia Program NIAMDD 1974 (unpublished)

    Google Scholar 

  71. Gotch FA, Sargent JA, Peters JH: Studies on the molecular etiology of uremia. Kidney Int 7 (suppl): S276, 1975

    Google Scholar 

  72. Henderson LW, Stone RA, Ford CA, Lysaght MJ: Blood pressure control with hemodiafiltration. Proc 10th Annual Contractors’ Conf Artif Kidney — Chronic Uremia Program NIAMDD 1977, p 110 (in press)

    Google Scholar 

  73. Funck-Brentano JL, Man NK, Sausse A, Cueille G, Zingraff J, Drueke T, Jungers P, Billon JP: Neuropathy and “middle” molecule toxins. Kidney Int 1 (suppl): S352, 1975

    Google Scholar 

  74. Gulyassy PF, Peters JH, Lin SC, Ryan PM: Hemodialysis and plasma amino acid composition in chronic renal failure. Am J Clin Nutr 21: 565, 1968

    PubMed  CAS  Google Scholar 

  75. Sargent JA, Gotch FA, Borah MF, Piercy L, Spinozzi N, Schoenfeld PY, Humphreys MH: Urea kinetics: A guide to nutrition management of renal failure. Am J Clin Nutr 1978

    Google Scholar 

Download references

Authors
  1. John A. Sargent
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Frank A. Gotch
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Medicine, University of Amsterdam, Netherlands

    William Drukker M.D. (Formerly Reader in Dialysis Emeritus Director) (Formerly Reader in Dialysis Emeritus Director)

  2. Department of Nephrology and Dialysis, St. Lucas Hospital, Amsterdam, The Netherlands

    William Drukker M.D. (Formerly Reader in Dialysis Emeritus Director) (Formerly Reader in Dialysis Emeritus Director)

  3. 75 De Lairessestreet, 1071 NV, Amsterdam, The Netherlands

    William Drukker M.D. (Formerly Reader in Dialysis Emeritus Director) (Formerly Reader in Dialysis Emeritus Director)

  4. Renal Research Unit, Wellcome Wing, The General Infirmary at Leeds, LS1 3EX, Leeds, UK

    Frank M. Parsons B.Sc., M.D., F.R.C.P. Ed. (Consultant Physician Senior Clinical Lecturer in Renal Medicine) (Consultant Physician Senior Clinical Lecturer in Renal Medicine)

  5. University of Leeds, UK

    Frank M. Parsons B.Sc., M.D., F.R.C.P. Ed. (Consultant Physician Senior Clinical Lecturer in Renal Medicine) (Consultant Physician Senior Clinical Lecturer in Renal Medicine)

  6. Health Center, University of Connecticut, 06032, Farmington, CT, USA

    John F. Maher M.D., F.A.C.P. (Professor of Medicine, Director Division of Nephrology) (Professor of Medicine, Director Division of Nephrology)

Rights and permissions

Reprints and permissions

Copyright information

© 1979 Martinus Nijhoff Publishers bv, The Hague

About this chapter

Cite this chapter

Sargent, J.A., Gotch, F.A. (1979). Principles and Biophysics of Dialysis. In: Drukker, W., Parsons, F.M., Maher, J.F. (eds) Replacement of Renal Function by Dialysis. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-9327-3_3

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-9327-3_3

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-90-247-2227-3

  • Online ISBN: 978-94-009-9327-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation